Breakout for Teladoc Health Stock in the Charts?

NYSE: TDOC | Teladoc Health, Inc.  News, Ratings, and Charts

TDOC – A level of resistance has formed in the chart of Teladoc Health (TDOC). If the stock breaks through this resistance, a breakout could occur. Read more to learn when to enter a position.

A key level of resistance has formed in the chart of Teladoc Health (TDOC).  If this level is broken, a breakout could occur.

TDOC is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the Internet, video, and phone. Its platform connects members with a network of physicians and behavioral health professionals.

The company has benefited from strong demand for the telehealth market during the pandemic. Its expansion into international markets should help boost growth over long-term. Acquisitions should also aid growth.

TDOC had $1.2 billion in cash at the end of the latest quarter, compared with $984 million in long-term debt. The company also has a sky-high current ratio, indicating it has more than enough liquidity to handle short-term obligations.

The company has seen huge sales growth. Revenue has risen an average of 62.1% over the past five years and is expected to rise 140.9% this quarter. Though the stock looks overvalued with a Price to Sales of 20.5 and a Price to Book of 15.1.

The stock has shown strong near and long-term momentum. This has led to a “Buy” rating in our POWR Ratings system. It holds a grade of “A” for Trade Grade, which is based on short-term momentum. This is reflected in the chart below.

Take a look at the 1-year chart of TDOC below with my added notations:

Chart of TDOC provided by TradingView

During the past five months, TDOC has formed a key level of resistance around the $235 (red) mark. The stock has tested that level multiple times since its August peak, and it is currently sitting right under that level again. A solid close above $235 should lead to higher prices for TDOC.

A long trade could be entered on a breakthrough of the $235 resistance level, with the expectation for a breakout.

Want to Discover More Great Trades?

I have explored virtually every flavor of technical analysis and chart pattern known to mankind. The sad fact is that the vast majority of them don’t work at all.

That is why I recently put together this special report to help investors focus on the only 5 chart patterns that matter…the ones that lead to the most timely and profitable stock trades. Click below to get your copy now!

5 WINNING Stock Chart Patterns

Have a good trading day!

Good luck!

Christian Tharp, CMT

@cmtstockcoach


TDOC shares fell $5.29 (-2.28%) in premarket trading Thursday. Year-to-date, TDOC has gained 13.12%, versus a 1.78% rise in the benchmark S&P 500 index during the same period.


About the Author: christian


Christian is an expert stock market coach at the Adam Mesh Trading Group who has mentored more than 4,000 traders and investors. He is a professional technical analyst that is a certified Chartered Market Technician (CMT), which is a designation awarded by the CMT Association. Christian is also the author of the daily online newsletter Todays Big Stock. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
TDOCGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

Is the Bull Market Over???

The past year for the S&P 500 (SPY) has been as bullish as they come. And yet seemingly out of nowhere investors have become very defensive of late. Why is this? And what does it mean for the future health of this bull market? Read on below for the answers…

:  |  News, Ratings, and Charts

2 Cathie Wood Stocks to Buy, 2 to Sell

Cathie Wood is betting on a genomic revolution because she believes it will be the next big industry disrupting development. We believe Wood’s favorite stocks, Vertex Pharmaceuticals Incorporated (VRTX) and Incyte Corporation (INCY), have attractive upside potential and are ideal investment bets now. Conversely, we think Wood’s investments in Fate Therapeutics, Inc. (FATE) and Twist Bioscience Corporation (TWST) may have a long journey before they can launch their products commercially. So, we believe they are best avoided now.

:  |  News, Ratings, and Charts

Top 10 Growth Stocks

Let me prove beyond a shadow of a doubt that we are in the midst of a stock market bubble. Even better, let me explain why stocks (SPY) will rise for another 12-24 months so you can ride it higher and then parachute out at the peak. And just for good measure I will share my top 10 stocks for today’s market. Read on below for more...

:  |  News, Ratings, and Charts

2 Chip Stocks That Could Soar in Q2 2021

Though the current semiconductor shortage is causing significant problems for many industries, semiconductor stocks are benefiting from increased demand. This is likely to continue to push certain semiconductor stocks higher in Q2.

:  |  News, Ratings, and Charts

Top 10 Growth Stocks

Let me prove beyond a shadow of a doubt that we are in the midst of a stock market bubble. Even better, let me explain why stocks (SPY) will rise for another 12-24 months so you can ride it higher and then parachute out at the peak. And just for good measure I will share my top 10 stocks for today’s market. Read on below for more...

Read More Stories

More Teladoc Health, Inc. (TDOC) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All TDOC News